Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bettelheim

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|May 1, 1992
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host diseaseP Valent, K C Sillaber, R Scherrer, et al.
Journal of the National Cancer Institute|May 15, 1991
MDR1 gene expression and treatment outcome in acute myeloid leukemiaR Pirker, J Wallner, K Geissler, et al.
Annals of Hematology|June 1, 1993
Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL)R Scherrer, K Geissler, P A Kyrle, et al.
Wiener Klinische Wochenschrift|February 1, 1985
[Cooperative studies in the treatment of acute lymphoblastic leukemia in children in Austria--report of 10 years' experience]H Gadner, P Krepler, M Kummer, et al.
Blood|November 1, 1992
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term cultureP Valent, E Spanblöchl, W R Sperr, et al.
Seminars in Hematology|July 1, 1991
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia|July 17, 1998
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparisonW Kern, C Aul, G Maschmeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
Interleukin 4 promotes expression of mast cell ICAM-1 antigenP Valent, D Bevec, D Maurer, et al.
Leukemia & Lymphoma|January 1, 1993
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Wiener Klinische Wochenschrift|March 6, 1987
[Right heart failure as a clinical sign of pulmonary artery sarcoma]P Bettelheim, M Hochmeister, C Herold, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|May 1, 1992
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host diseaseP Valent, K C Sillaber, R Scherrer, et al.
Journal of the National Cancer Institute|May 15, 1991
MDR1 gene expression and treatment outcome in acute myeloid leukemiaR Pirker, J Wallner, K Geissler, et al.
Annals of Hematology|June 1, 1993
Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL)R Scherrer, K Geissler, P A Kyrle, et al.
Wiener Klinische Wochenschrift|February 1, 1985
[Cooperative studies in the treatment of acute lymphoblastic leukemia in children in Austria--report of 10 years' experience]H Gadner, P Krepler, M Kummer, et al.
Blood|November 1, 1992
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term cultureP Valent, E Spanblöchl, W R Sperr, et al.
Seminars in Hematology|July 1, 1991
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia|July 17, 1998
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparisonW Kern, C Aul, G Maschmeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
Interleukin 4 promotes expression of mast cell ICAM-1 antigenP Valent, D Bevec, D Maurer, et al.
Leukemia & Lymphoma|January 1, 1993
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Wiener Klinische Wochenschrift|March 6, 1987
[Right heart failure as a clinical sign of pulmonary artery sarcoma]P Bettelheim, M Hochmeister, C Herold, et al.
Pageof 14